Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer

A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer

NCT02362958 ·Status: COMPLETED ·Phase: PHASE2

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response

NCT00483223 ·Status: COMPLETED ·Phase: PHASE2

Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body

NCT05198843 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer

NCT01112826 ·Status: COMPLETED ·Phase: PHASE3

Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC

NCT03295552 ·Status: TERMINATED ·Phase: PHASE2

Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer

NCT04134884 ·Status: COMPLETED ·Phase: PHASE1

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

NCT01492556 ·Status: UNKNOWN ·Phase: PHASE2

Anlotinib in Metastatic HER2 Negative Breast Cancer

NCT04002284 ·Status: COMPLETED ·Phase: PHASE2

Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer

NCT05089643 ·Status: UNKNOWN ·Phase: PHASE2

A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.

NCT06839547 ·Status: NOT_YET_RECRUITING

Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

NCT04059484 ·Status: TERMINATED ·Phase: PHASE2

Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer

NCT01207102 ·Status: TERMINATED ·Phase: PHASE2

Clinical Study of Apatinib Combined With SBRT Therapy in the Treatment of Oligometastasis of Breast Cancer

NCT03457467 ·Status: UNKNOWN ·Phase: PHASE2

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

NCT03483012 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.

NCT00034489 ·Status: COMPLETED ·Phase: PHASE2

Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer

NCT00931450 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

NCT06434064 ·Status: RECRUITING ·Phase: PHASE2

3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer

NCT00095888 ·Status: TERMINATED ·Phase: PHASE2

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

NCT07092254 ·Status: ACTIVE_NOT_RECRUITING

Carboplatin With or Without ZD4054 in Patients With Metastatic Breast Cancer

NCT01134497 ·Status: WITHDRAWN ·Phase: PHASE2

Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)

NCT06618014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

NCT04452370 ·Status: UNKNOWN ·Phase: PHASE2

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

NCT03691493 ·Status: COMPLETED ·Phase: PHASE2

Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE)

NCT05359120 ·Status: UNKNOWN

Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer

NCT00802945 ·Status: COMPLETED ·Phase: PHASE2